# V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis

> **NCT00175513** · PHASE2 · COMPLETED · sponsor: **University of British Columbia** · enrollment: 100 (estimated)

## Conditions studied

- Psychosis

## Interventions

- **DRUG:** Valacyclovir (Valtrex)

## Key facts

- **NCT ID:** NCT00175513
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00175513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00175513, "V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00175513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*